TESTIS RISK AND PROGNOSTIC FACTORS: The Pathologist's Perspective
- 1 August 1999
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 26 (3) , 611-626
- https://doi.org/10.1016/s0094-0143(05)70202-0
Abstract
No abstract availableKeywords
This publication has 95 references indexed in Scilit:
- The prevalence of familial testicular cancerCancer, 1997
- ARTICLES: Testicular Nonseminoma and Seminoma in Relation to Perinatal CharacteristicsJNCI Journal of the National Cancer Institute, 1996
- Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resectionsEuropean Journal Of Cancer, 1994
- Bilateral testicular tumours: Prevalence and clinical implicationsEuropean Journal Of Cancer, 1993
- Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cellsHistopathology, 1993
- Surveillance following orchidectomy for stage I seminoma of the testisEuropean Journal Of Cancer, 1993
- RESIDUAL CARCINOMA-IN-SITU OF CONTRALATERAL TESTIS AFTER CHEMOTHERAPYThe Lancet, 1988
- Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesisThe Journal of Pediatrics, 1985
- Cryptorchidism and testis cancer. Atypical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthoodCancer, 1984
- Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer.BMJ, 1982